| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $376.9M | -39.0% |
| Cost of Revenue | $152.2M | -15.9% |
| Gross Profit | $224.8M | -48.5% |
| R&D Expense | $93.5M | -45.2% |
| SG&A Expense | $177.4M | -18.5% |
| Operating Income | -$116.9M | +84.1% |
| Pre-tax Income | -$100.1M | +85.5% |
| Income Tax | $3.3M | -97.8% |
| Net Income | -$103.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $31.1M | -80.7% |
| Short-term Investments | $41.7M | -73.0% |
| Accounts Receivable | $15.6M | -34.0% |
| Current Assets | $121.6M | -72.2% |
| Total Assets | $278.0M | -68.0% |
| Current Liabilities | $140.9M | -73.3% |
| Total Liabilities | $158.4M | -76.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $15.5M | -87.6% |
| Capital Expenditures | $28.1M | -62.5% |
| Investing Cash Flow | $282.3M | +2388.3% |
| Financing Cash Flow | -$428.5M | -292.6% |
| Free Cash Flow | -$12.6M | -125.1% |
| +87.6% |
| EPS (Basic) | -$0.96 | +88.1% |
| EPS (Diluted) | -$0.96 | +88.1% |
| Stockholders' Equity |
| $119.6M |
| -38.0% |